Physician profile
Mary Batson
NPI 1861014631
$2,561.21
in general payments reported to CMS, 2019-2025
22 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,022 · 2023: $959 · 2024: $238 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,534 · Travel and Lodging: $5.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,534.41 |
| Travel and Lodging | $5.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $320.06 | 2022-2025 | Lithovue, Solyx Sis System, Rezum Generator |
| Medtronic, INC. | $280.58 | 2022-2025 | Interstim |
| Coloplast Corp | $273.78 | 2022-2023 | Speedicath, Saffron |
| Halozyme INC | $220.40 | 2023 | |
| Janssen Biotech, INC. | $212.03 | 2022-2023 | Erleada |
| Antares Pharma, INC. | $198.67 | 2022-2023 | Nocdurna, Tlando, Xyosted |
| Bayer Healthcare Pharmaceuticals INC. | $188.25 | 2022 | |
| Astellas Pharma US INC | $184.98 | 2022-2023 | Myrbetriq |
| Bioprotect Medical, INC. | $140.18 | 2024-2025 | Bioprotect Balloon Implant System |
| Srs Medical Systems, INC. | $95.17 | 2024 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Merck Sharp & Dohme LLC | $92.29 | 2022-2023 | Welireg, Keytruda |
| Sumitomo Pharma America, INC. | $73.24 | 2023-2025 | Gemtesa |
| Abc Home Medical Supply, INC. | $44.68 | 2022-2023 | |
| C. R. Bard, INC. & Subsidiaries | $44.20 | 2023 | |
| Abbvie INC. | $36.29 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $35.89 | 2022-2023 | Jelmyto |
| Endo Pharmaceuticals INC. | $32.26 | 2022 | |
| Urovant Sciences INC | $25.82 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.15 | 2022 | |
| Teleflex LLC | $17.47 | 2023 | Urolift |
| Axonics, INC. | $14.05 | 2022 | |
| Acerus Pharmaceuticals Corporation | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Batson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.